Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Weight Loss Drug Ban Upheld (Australia)

This article was originally published in PharmAsia News

Executive Summary

The Australian Federal Court rejected an appeal by top drug manufacturer Roche to reverse a ban preventing them from publicly advertising the weight-loss drug Xenical. The ban was handed down in February by an Australian federal health committee. The committee claimed that Xenical should not be publicly advertised because they felt Roche's marketing campaign might pressure pharmacists to give the drug to individuals it was not designed for, particularly teenagers. Xenical is intended to reduce the weight of extremely obese individuals but it can also have some unwanted side effects, like nausea and abdominal pain. (Click here for more - May Require Free Registration
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC066566

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel